Improvement of gut microbiome and intestinal permeability following splenectomy plus pericardial devascularization in hepatitis B virus-related cirrhotic portal hypertension
The gut microbiome is an essential component of the intestinal mucosal barrier, critical in regulating intestinal permeability. Microbiome dysbiosis and intestinal permeability changes are commonly encountered conditions in patients with cirrhosis and are closely related to its development and furth...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-09-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.941830/full |
_version_ | 1798002162339414016 |
---|---|
author | Yang Zhao Yang Zhao Rui Zhou Rui Zhou Ying Guo Ying Guo Xi Chen Xi Chen Aiyu Zhang Aiyu Zhang Jiayin Wang Fanpu Ji Fanpu Ji Fanpu Ji Bowen Qin Bowen Qin Jing Geng Jing Geng Guangyao Kong Guangyao Kong Zongfang Li Zongfang Li Zongfang Li |
author_facet | Yang Zhao Yang Zhao Rui Zhou Rui Zhou Ying Guo Ying Guo Xi Chen Xi Chen Aiyu Zhang Aiyu Zhang Jiayin Wang Fanpu Ji Fanpu Ji Fanpu Ji Bowen Qin Bowen Qin Jing Geng Jing Geng Guangyao Kong Guangyao Kong Zongfang Li Zongfang Li Zongfang Li |
author_sort | Yang Zhao |
collection | DOAJ |
description | The gut microbiome is an essential component of the intestinal mucosal barrier, critical in regulating intestinal permeability. Microbiome dysbiosis and intestinal permeability changes are commonly encountered conditions in patients with cirrhosis and are closely related to its development and further complications. However, alterations in the gut microbiome and intestinal permeability in chronic hepatitis B virus (HBV) patients with cirrhotic portal hypertension after undergoing a splenectomy plus pericardial devascularization (SPD) have not been investigated. This study recruited 22 patients who were measured against themselves on the study parameters before and after an SPD, along with 20 healthy controls. Methodologically, fecal samples were collected for gut microbiome analysis by 16S ribosomal DNA sequencing, and peripheral blood samples were obtained to examine the liver function and intestinal permeability. This study showed that the community structure of the gut microbiomes in patients before the SPD exhibited obvious differences from those in the healthy control group. They also exhibited a decreased bacterial community richness, increased intestinal permeability, and enhanced inflammation compared with the healthy controls. These issues were further aggravated two weeks after the SPD. There was also evidence of significantly higher abundances of Streptococcaceae, Enterobacteriaceae, and Enterococcaceae than those in the healthy control group. However, 12 months after the surgery, 12 of the 16 patient-associated genera recovered, of which 10 reached normal levels. Additionally, the microbiome diversity increased; the bacterial composition was back to a level similar to the healthy controls. Liver function, intestinal permeability, and inflammation levels all improved compared with preoperative levels. Furthermore, correlation analyses indicated that the five recovered bacterial taxa and the Shannon diversity index were correlated with several improved clinical indicators. Altogether, the improvements in the liver function and intestinal permeability in HBV-related cirrhotic patients may be related to the restoration of the gut microbiome after an SPD. |
first_indexed | 2024-04-11T11:47:47Z |
format | Article |
id | doaj.art-8936485a604c4011bfb8c08bc6f9d4f6 |
institution | Directory Open Access Journal |
issn | 1664-3224 |
language | English |
last_indexed | 2024-04-11T11:47:47Z |
publishDate | 2022-09-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Immunology |
spelling | doaj.art-8936485a604c4011bfb8c08bc6f9d4f62022-12-22T04:25:29ZengFrontiers Media S.A.Frontiers in Immunology1664-32242022-09-011310.3389/fimmu.2022.941830941830Improvement of gut microbiome and intestinal permeability following splenectomy plus pericardial devascularization in hepatitis B virus-related cirrhotic portal hypertensionYang Zhao0Yang Zhao1Rui Zhou2Rui Zhou3Ying Guo4Ying Guo5Xi Chen6Xi Chen7Aiyu Zhang8Aiyu Zhang9Jiayin Wang10Fanpu Ji11Fanpu Ji12Fanpu Ji13Bowen Qin14Bowen Qin15Jing Geng16Jing Geng17Guangyao Kong18Guangyao Kong19Zongfang Li20Zongfang Li21Zongfang Li22Shaanxi Provincial Clinical Research Center for Hepatic & Splenic Diseases, The Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, ChinaNational & Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, ChinaShaanxi Provincial Clinical Research Center for Hepatic & Splenic Diseases, The Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, ChinaDepartment of Hepatobiliary Surgery, The Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, ChinaShaanxi Provincial Clinical Research Center for Hepatic & Splenic Diseases, The Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, ChinaNational & Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, ChinaShaanxi Provincial Clinical Research Center for Hepatic & Splenic Diseases, The Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, ChinaNational & Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, ChinaShaanxi Provincial Clinical Research Center for Hepatic & Splenic Diseases, The Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, ChinaNational & Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, ChinaSchool of Computer Science and Technology, Xi’an Jiaotong University, Xi’an, ChinaShaanxi Provincial Clinical Research Center for Hepatic & Splenic Diseases, The Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, ChinaNational & Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, ChinaDepartment of Infectious Diseases, The Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, ChinaShaanxi Provincial Clinical Research Center for Hepatic & Splenic Diseases, The Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, ChinaNational & Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, ChinaShaanxi Provincial Clinical Research Center for Hepatic & Splenic Diseases, The Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, ChinaNational & Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, ChinaShaanxi Provincial Clinical Research Center for Hepatic & Splenic Diseases, The Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, ChinaNational & Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, ChinaShaanxi Provincial Clinical Research Center for Hepatic & Splenic Diseases, The Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, ChinaNational & Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, ChinaDepartment of Hepatobiliary Surgery, The Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, ChinaThe gut microbiome is an essential component of the intestinal mucosal barrier, critical in regulating intestinal permeability. Microbiome dysbiosis and intestinal permeability changes are commonly encountered conditions in patients with cirrhosis and are closely related to its development and further complications. However, alterations in the gut microbiome and intestinal permeability in chronic hepatitis B virus (HBV) patients with cirrhotic portal hypertension after undergoing a splenectomy plus pericardial devascularization (SPD) have not been investigated. This study recruited 22 patients who were measured against themselves on the study parameters before and after an SPD, along with 20 healthy controls. Methodologically, fecal samples were collected for gut microbiome analysis by 16S ribosomal DNA sequencing, and peripheral blood samples were obtained to examine the liver function and intestinal permeability. This study showed that the community structure of the gut microbiomes in patients before the SPD exhibited obvious differences from those in the healthy control group. They also exhibited a decreased bacterial community richness, increased intestinal permeability, and enhanced inflammation compared with the healthy controls. These issues were further aggravated two weeks after the SPD. There was also evidence of significantly higher abundances of Streptococcaceae, Enterobacteriaceae, and Enterococcaceae than those in the healthy control group. However, 12 months after the surgery, 12 of the 16 patient-associated genera recovered, of which 10 reached normal levels. Additionally, the microbiome diversity increased; the bacterial composition was back to a level similar to the healthy controls. Liver function, intestinal permeability, and inflammation levels all improved compared with preoperative levels. Furthermore, correlation analyses indicated that the five recovered bacterial taxa and the Shannon diversity index were correlated with several improved clinical indicators. Altogether, the improvements in the liver function and intestinal permeability in HBV-related cirrhotic patients may be related to the restoration of the gut microbiome after an SPD.https://www.frontiersin.org/articles/10.3389/fimmu.2022.941830/fullliver cirrhosisportal hypertensionsplenectomygut microbiomeintestinal permeability |
spellingShingle | Yang Zhao Yang Zhao Rui Zhou Rui Zhou Ying Guo Ying Guo Xi Chen Xi Chen Aiyu Zhang Aiyu Zhang Jiayin Wang Fanpu Ji Fanpu Ji Fanpu Ji Bowen Qin Bowen Qin Jing Geng Jing Geng Guangyao Kong Guangyao Kong Zongfang Li Zongfang Li Zongfang Li Improvement of gut microbiome and intestinal permeability following splenectomy plus pericardial devascularization in hepatitis B virus-related cirrhotic portal hypertension Frontiers in Immunology liver cirrhosis portal hypertension splenectomy gut microbiome intestinal permeability |
title | Improvement of gut microbiome and intestinal permeability following splenectomy plus pericardial devascularization in hepatitis B virus-related cirrhotic portal hypertension |
title_full | Improvement of gut microbiome and intestinal permeability following splenectomy plus pericardial devascularization in hepatitis B virus-related cirrhotic portal hypertension |
title_fullStr | Improvement of gut microbiome and intestinal permeability following splenectomy plus pericardial devascularization in hepatitis B virus-related cirrhotic portal hypertension |
title_full_unstemmed | Improvement of gut microbiome and intestinal permeability following splenectomy plus pericardial devascularization in hepatitis B virus-related cirrhotic portal hypertension |
title_short | Improvement of gut microbiome and intestinal permeability following splenectomy plus pericardial devascularization in hepatitis B virus-related cirrhotic portal hypertension |
title_sort | improvement of gut microbiome and intestinal permeability following splenectomy plus pericardial devascularization in hepatitis b virus related cirrhotic portal hypertension |
topic | liver cirrhosis portal hypertension splenectomy gut microbiome intestinal permeability |
url | https://www.frontiersin.org/articles/10.3389/fimmu.2022.941830/full |
work_keys_str_mv | AT yangzhao improvementofgutmicrobiomeandintestinalpermeabilityfollowingsplenectomypluspericardialdevascularizationinhepatitisbvirusrelatedcirrhoticportalhypertension AT yangzhao improvementofgutmicrobiomeandintestinalpermeabilityfollowingsplenectomypluspericardialdevascularizationinhepatitisbvirusrelatedcirrhoticportalhypertension AT ruizhou improvementofgutmicrobiomeandintestinalpermeabilityfollowingsplenectomypluspericardialdevascularizationinhepatitisbvirusrelatedcirrhoticportalhypertension AT ruizhou improvementofgutmicrobiomeandintestinalpermeabilityfollowingsplenectomypluspericardialdevascularizationinhepatitisbvirusrelatedcirrhoticportalhypertension AT yingguo improvementofgutmicrobiomeandintestinalpermeabilityfollowingsplenectomypluspericardialdevascularizationinhepatitisbvirusrelatedcirrhoticportalhypertension AT yingguo improvementofgutmicrobiomeandintestinalpermeabilityfollowingsplenectomypluspericardialdevascularizationinhepatitisbvirusrelatedcirrhoticportalhypertension AT xichen improvementofgutmicrobiomeandintestinalpermeabilityfollowingsplenectomypluspericardialdevascularizationinhepatitisbvirusrelatedcirrhoticportalhypertension AT xichen improvementofgutmicrobiomeandintestinalpermeabilityfollowingsplenectomypluspericardialdevascularizationinhepatitisbvirusrelatedcirrhoticportalhypertension AT aiyuzhang improvementofgutmicrobiomeandintestinalpermeabilityfollowingsplenectomypluspericardialdevascularizationinhepatitisbvirusrelatedcirrhoticportalhypertension AT aiyuzhang improvementofgutmicrobiomeandintestinalpermeabilityfollowingsplenectomypluspericardialdevascularizationinhepatitisbvirusrelatedcirrhoticportalhypertension AT jiayinwang improvementofgutmicrobiomeandintestinalpermeabilityfollowingsplenectomypluspericardialdevascularizationinhepatitisbvirusrelatedcirrhoticportalhypertension AT fanpuji improvementofgutmicrobiomeandintestinalpermeabilityfollowingsplenectomypluspericardialdevascularizationinhepatitisbvirusrelatedcirrhoticportalhypertension AT fanpuji improvementofgutmicrobiomeandintestinalpermeabilityfollowingsplenectomypluspericardialdevascularizationinhepatitisbvirusrelatedcirrhoticportalhypertension AT fanpuji improvementofgutmicrobiomeandintestinalpermeabilityfollowingsplenectomypluspericardialdevascularizationinhepatitisbvirusrelatedcirrhoticportalhypertension AT bowenqin improvementofgutmicrobiomeandintestinalpermeabilityfollowingsplenectomypluspericardialdevascularizationinhepatitisbvirusrelatedcirrhoticportalhypertension AT bowenqin improvementofgutmicrobiomeandintestinalpermeabilityfollowingsplenectomypluspericardialdevascularizationinhepatitisbvirusrelatedcirrhoticportalhypertension AT jinggeng improvementofgutmicrobiomeandintestinalpermeabilityfollowingsplenectomypluspericardialdevascularizationinhepatitisbvirusrelatedcirrhoticportalhypertension AT jinggeng improvementofgutmicrobiomeandintestinalpermeabilityfollowingsplenectomypluspericardialdevascularizationinhepatitisbvirusrelatedcirrhoticportalhypertension AT guangyaokong improvementofgutmicrobiomeandintestinalpermeabilityfollowingsplenectomypluspericardialdevascularizationinhepatitisbvirusrelatedcirrhoticportalhypertension AT guangyaokong improvementofgutmicrobiomeandintestinalpermeabilityfollowingsplenectomypluspericardialdevascularizationinhepatitisbvirusrelatedcirrhoticportalhypertension AT zongfangli improvementofgutmicrobiomeandintestinalpermeabilityfollowingsplenectomypluspericardialdevascularizationinhepatitisbvirusrelatedcirrhoticportalhypertension AT zongfangli improvementofgutmicrobiomeandintestinalpermeabilityfollowingsplenectomypluspericardialdevascularizationinhepatitisbvirusrelatedcirrhoticportalhypertension AT zongfangli improvementofgutmicrobiomeandintestinalpermeabilityfollowingsplenectomypluspericardialdevascularizationinhepatitisbvirusrelatedcirrhoticportalhypertension |